291 related articles for article (PubMed ID: 17913309)
1. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge.
Cox SJ; Parida S; Voyce C; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2007 Nov; 25(44):7687-95. PubMed ID: 17913309
[TBL] [Abstract][Full Text] [Related]
2. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Hutchings G; Paton DJ; Barnett PV
Vaccine; 2006 Apr; 24(16):3184-90. PubMed ID: 16488060
[TBL] [Abstract][Full Text] [Related]
3. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx.
Cox SJ; Voyce C; Parida S; Reid SM; Hamblin PA; Paton DJ; Barnett PV
Vaccine; 2005 Jan; 23(9):1106-13. PubMed ID: 15629353
[TBL] [Abstract][Full Text] [Related]
4. The effect of vaccination on foot and mouth disease virus transmission among dairy cows.
Orsel K; de Jong MC; Bouma A; Stegeman JA; Dekker A
Vaccine; 2007 Jan; 25(2):327-35. PubMed ID: 16949184
[TBL] [Abstract][Full Text] [Related]
5. Vaccination against foot and mouth disease reduces virus transmission in groups of calves.
Orsel K; Dekker A; Bouma A; Stegeman JA; de Jong MC
Vaccine; 2005 Sep; 23(41):4887-94. PubMed ID: 16002192
[TBL] [Abstract][Full Text] [Related]
6. Effect of FMD vaccine antigen payload on protection, sub-clinical infection and persistence following needle challenge in sheep.
Madhanmohan M; Nagendrakumar SB; Narasu ML; Srinivasan VA
Comp Immunol Microbiol Infect Dis; 2010 Dec; 33(6):e7-13. PubMed ID: 19896714
[TBL] [Abstract][Full Text] [Related]
7. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs.
Eblé PL; Bouma A; Weerdmeester K; Stegeman JA; Dekker A
Vaccine; 2007 Jan; 25(6):1043-54. PubMed ID: 17157418
[TBL] [Abstract][Full Text] [Related]
8. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
Grubman MJ
Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
[TBL] [Abstract][Full Text] [Related]
9. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: Use in emergency outbreak response.
Golde WT; Pacheco JM; Duque H; Doel T; Penfold B; Ferman GS; Gregg DR; Rodriguez LL
Vaccine; 2005 Dec; 23(50):5775-82. PubMed ID: 16153756
[TBL] [Abstract][Full Text] [Related]
10. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease.
Parida S; Cox SJ; Reid SM; Hamblin P; Barnett PV; Inoue T; Anderson J; Paton DJ
Vaccine; 2005 Oct; 23(44):5186-95. PubMed ID: 16039761
[TBL] [Abstract][Full Text] [Related]
11. Transmission of foot-and-mouth disease by vaccinated cattle following natural challenge.
Donaldson AI; Kitching RP
Res Vet Sci; 1989 Jan; 46(1):9-14. PubMed ID: 2537993
[TBL] [Abstract][Full Text] [Related]
12. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep.
Barnett PV; Keel P; Reid S; Armstrong RM; Statham RJ; Voyce C; Aggarwal N; Cox SJ
Vaccine; 2004 Mar; 22(9-10):1221-32. PubMed ID: 15003651
[TBL] [Abstract][Full Text] [Related]
13. Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle.
Fowler VL; Paton DJ; Rieder E; Barnett PV
Vaccine; 2008 Apr; 26(16):1982-9. PubMed ID: 18342409
[TBL] [Abstract][Full Text] [Related]
14. Detection of foot-and-mouth disease virus infection in vaccinated cattle.
Niedbalski W
Pol J Vet Sci; 2005; 8(4):283-7. PubMed ID: 16385852
[TBL] [Abstract][Full Text] [Related]
15. Detection of carriers of foot-and-mouth disease virus among vaccinated cattle.
Moonen P; Jacobs L; Crienen A; Dekker A
Vet Microbiol; 2004 Nov; 103(3-4):151-60. PubMed ID: 15504586
[TBL] [Abstract][Full Text] [Related]
16. High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus.
Brehm KE; Kumar N; Thulke HH; Haas B
Vaccine; 2008 Mar; 26(13):1681-7. PubMed ID: 18313814
[TBL] [Abstract][Full Text] [Related]
17. Cedivac-FMD can be used according to a marker vaccine principle.
Chénard G; Selman P; Dekker A
Vet Microbiol; 2008 Apr; 128(1-2):65-71. PubMed ID: 18035508
[TBL] [Abstract][Full Text] [Related]
18. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle.
Paton DJ; de Clercq K; Greiner M; Dekker A; Brocchi E; Bergmann I; Sammin DJ; Gubbins S; Parida S
Vaccine; 2006 Oct; 24(42-43):6503-12. PubMed ID: 16872727
[TBL] [Abstract][Full Text] [Related]
19. The NSP immune response of vaccinated animals after in-field exposure to FMDV.
Yadin H; Brenner J; Chai D; Oved Z; Hadany Y; Kusak A; Haimovich M
Vaccine; 2007 Nov; 25(49):8298-305. PubMed ID: 17981376
[TBL] [Abstract][Full Text] [Related]
20. Induction of mucosal immune responses and protection of cattle against direct-contact challenge by intranasal delivery with foot-and-mouth disease virus antigen mediated by nanoparticles.
Pan L; Zhang Z; Lv J; Zhou P; Hu W; Fang Y; Chen H; Liu X; Shao J; Zhao F; Ding Y; Lin T; Chang H; Zhang J; Zhang Y; Wang Y
Int J Nanomedicine; 2014; 9():5603-18. PubMed ID: 25506214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
